Cardiology Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cover Story

Cardiologists grapple with potential CV risks posed by e-cigarettes

FDA News

Treatments for cardiomyopathy from transthyretin-mediated amyloidosis approved by FDA

FDA approves Fragmin, first anticoagulant for children

In the Journals

AHA: Despite improvements in HIV treatment, CVD risk elevated

End-stage renal disease increases risk for mortality, bleeding after TAVR

Neladenoson not beneficial in HFpEF

Familial hypercholesterolemia screening in blood donations may diagnose more patients

Frequent energy drink consumption may be harmful to heart

Meeting News

Components of Mediterranean diet can be individualized for goal attainment

Alteplase effective up to 9 hours after ischemic stroke

REAFFIRM: Rotor ablation similar to conventional ablation in persistent AF

Pulsed field ablation safe for paroxysmal AF

Price reductions of PCSK9 inhibitors contributed to greater cost-effectiveness

ORION-3: Inclisiran safely reduces LDL by more than 50%

Next Gen Innovator wins award for paper on His bundle pacing

Bempedoic acid with PCSK9 inhibitor safely reduces lipids

ULTIMATE: IVUS guidance may mitigate poor PCI outcomes in chronic kidney disease

FFR changes treatment plan after angiography in more than 30% of cases

Cardiogenic shock protocol improves survival

Exercise should be emphasized in patients with dyslipidemia

Pharmacology Consult

Out of the loop: Augmenting diuresis with SGLT2 inhibitors in HF

Megan Valente, PharmD, BCACP; Kathleen D. Faulkenberg, PharmD, BCPS

Trial Scorecards

CAPTURE

COMMENCE

CHOICE

RACE 7 ACWAS

REAFFIRM

EXPAND

ImpACT24-B

ORION-3